Letter: Adrenal unresponsiveness associated with clobetasol propionate.
D000287:Administration, Topical; D000311:Adrenal Glands / Q000187:drug effects*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004485:Eczema / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D009824:Ointments; D011244:Pregnadienediols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011422:Propionates / Q000494:pharmacology / Q000627:therapeutic use; D012869:Skin Absorption; D013258:Steroids, Chlorinated / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013259:Steroids, Fluorinated / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D009824:Ointments; D011244:Pregnadienediols; D011422:Propionates; D013258:Steroids, Chlorinated; D013259:Steroids, Fluorinated; D006854:Hydrocortisone